Skip to main navigation
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact

Quarterly Results

Investor Menu

IR Nav

  • Overview
  • News & Events
    News Releases Events Publications
  • Financials
    SEC Filings Quarterly Results
  • Stock
    Stock Performance Analyst Coverage
  • Corporate Governance
    Governance Documents Leadership Board of Directors Committee Composition
  • Resources
    Investor FAQs Contact Us Email Alerts

2026

Q1

  • Press Release

2025

Q4

  • Press Release

Q3

  • Press Release

Q2

  • Press Release

Q1

  • Press Release

2024

Q4

  • Press Release
  • Form 20-F

Q3

  • Press Release

Q2

  • Press Release

Q1

  • Press Release

2023

Q4

  • Press Release
  • Form 20-F

Q3

  • Press Release

Q2

  • Press Release

Q1

  • Press Release

2022

Q4

  • Press Release
  • Form 20-F

Q3

  • Press Release

Q2

  • Press Release

Q1

  • Press Release

2021

Q4

  • Press Realease
  • Form 20-F

Q3

  • Press Release

Q2

  • Press Release

Q1

  • Press Release
Pharvaris N.V.

©2026 Pharvaris N.V. © All Rights Reserved

Menu
  • Privacy Policy
  • Clinical Trial Privacy Notice
  • Global Privacy Laws
  • Terms of Use
CONTACT US
FOLLOW US